Related Companies

• EiRx Therapeutics

Related Indices

• FTSE AIM All-Share

Related Sectors

• Pharmaceuticals & Biotechnology

News for Spread Betters

Previous

Next

There's a new Investor Edition of CMC Markets' spread betting platform... and it's exclusive to DigitalLook.com users...

Get full details about Marketmaker:Investor Edition here.

News for Spread Betters

Previous

Next

There's a new Investor Edition of CMC Markets' spread betting platform... and it's exclusive to DigitalLook.com users...

Get full details about Marketmaker:Investor Edition here.

Unsecured Loans

Previous

Next

Lighten the load of all those repayments with a low rate unsecured loan. This month's selected offers:

1. Barclays Loans
2. Halifax Loans

AMEX Platinum

Previous

Next

Money back on your spendings? With American Express Platinum MoneyBack card, you can get

• 5% Money Back* during your first 3 months, then
• standard Money Back rate up to 1.5% with
• typical APR 18.9% variable

Why look further? Apply now!

Digital Look's Best Picks

Previous

Next

Your money can work for you! Get it going with one of this month’s high interest current accounts:

1. A&L Premier Direct
2. Coventry First Account
3. Co-operative Current Plus

Date: Wednesday 20 Aug 2008

LONDON (ShareCast) - Cork-based drug discovery firm Eirx Therapeutics has applied to put its wholly owned Irish subsidiary Eirx Therapeutics into liquidation and lost its CEO.

Chief executive Colin Telfer has been made redundant as part of the liquidation process and resigned as a director, it was confirmed today.

Directors John Pool, Nick Strong and Tom Cotter are “working to put together a plan designed to secure the future of the company based around its other operating business, Auvation Limited.”

The shares were suspended last month as the company struggles to secure sufficient funds to keep going.

• News Channel